| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f4242f0a829ca0ed2715260c94099f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff7042d4c4d150250a31ff587c7cfee7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adbfb31b2bece8edb8e7be51c2e1c043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0723ac2f397223ca017c2963d0a599e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0edd7478d4aa4642a6e9eada2a01f101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_380f2c9b8de15bfae90d6ff6f6a397ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_717b26b46b061cb77ad1e677293b683e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a46a6ed41c9a1939bbc099e0f8c7941 |
| publicationDate |
2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018204760-A1 |
| titleOfInvention |
Ctla4 antibodies and vaccine combinations and use of same for immunotherapy |
| abstract |
Disclosed herein is an immunogenic composition comprising at least an antigen and CTLA4 antibody. Also disclosed herein is a method for enhancing an immune response in a subject. The method may comprise administering the immunogenic composition to the subject in need thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844119-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021216920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023105221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3518955-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10882908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464841-B2 |
| priorityDate |
2017-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |